NEUROENDOCRINE CARCINOMAS (NEC)
Clinical trials for NEUROENDOCRINE CARCINOMAS (NEC) explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE CARCINOMAS (NEC) trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMAS (NEC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare cancer: experimental drug targets tough tumors
Disease control Recruiting nowThis study tests a drug called tarlatamab in 60 adults with a rare, advanced cancer called extrapulmonary neuroendocrine carcinoma that has come back after standard chemotherapy. The drug works by helping the immune system attack cancer cells. The main goal is to see how many pat…
Matched conditions: NEUROENDOCRINE CARCINOMAS (NEC)
Phase: PHASE2 • Sponsor: Inkeun Park • Aim: Disease control
Last updated May 26, 2026 07:33 UTC
-
New drug targets hard-to-treat neuroendocrine cancers in early trial
Disease control Recruiting nowThis study tests a new drug, peluntamig, in people with advanced neuroendocrine cancers (like small cell lung cancer) that have a specific marker called DLL3. The trial has two parts: first finding the safest dose, then testing it alone or with chemotherapy. About 203 participant…
Matched conditions: NEUROENDOCRINE CARCINOMAS (NEC)
Phase: PHASE1, PHASE2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated May 01, 2026 16:00 UTC